Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac
- DOI
- 10.1007/s00259-026-08076-x
- Published
- 2026-07-15
- Container
- European Journal of Nuclear Medicine and Molecular Imaging
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-026-08076-x,
title = {Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac},
author = {Robin I.J. Merkx and Simone C. Kleinendorst and Mark Rijpkema and Gerben M. Franssen and Alfred Morgenstern and Frank Bruchertseifer and Michael P. Wheatcroft and Egbert Oosterwijk and Peter F.A. Mulders and Mark Konijnenberg and Sandra Heskamp},
year = {2026},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
doi = {10.1007/s00259-026-08076-x},
url = {https://doi.org/10.1007/s00259-026-08076-x}
}RIS
TY - JOUR TI - Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac AU - Robin I.J. Merkx AU - Simone C. Kleinendorst AU - Mark Rijpkema AU - Gerben M. Franssen AU - Alfred Morgenstern AU - Frank Bruchertseifer AU - Michael P. Wheatcroft AU - Egbert Oosterwijk AU - Peter F.A. Mulders AU - Mark Konijnenberg AU - Sandra Heskamp PY - 2026 JO - European Journal of Nuclear Medicine and Molecular Imaging DO - 10.1007/s00259-026-08076-x UR - https://doi.org/10.1007/s00259-026-08076-x ER -
APA
Merkx, R. I., Kleinendorst, S. C., Rijpkema, M., Franssen, G. M., Morgenstern, A., Bruchertseifer, F., Wheatcroft, M. P., Oosterwijk, E., Mulders, P. F., Konijnenberg, M., & Heskamp, S. (2026). Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08076-x
Source records
- crossref · retrieved 2026-09-27T01:59:24.568Z